{"data":{"id":"us-ga/o.c.g.a.-31-52-4","jurisdiction":"us-ga","citation":"O.C.G.A. § 31-52-4","heading":"Eligibility criteria.","body":"In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:\n(1) Has a terminal illness;\n(2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;\n(3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and\n(4) Has given written informed consent for the use of the investigational drug, biological product, or device.","path":["TITLE 31 Health","CHAPTER 52 Terminally Ill Patient’s Right To Try Investigational Drugs, Biological Products, and Devices"],"source_url":"https://archive.org/download/gov.ga.ocga.2018/release86.2022.11/gov.ga.ocga.title.31.odt","current_through":"Release 86 (2022-11)","vintage":"Public.Resource.Org bulk O.C.G.A., Release 86 (2022-11), retrieved 2026-09-17","retrieved_at":"2026-09-17T19:34:57Z","sha256":"01557c289a13f85bc2e34ecf7546935915595cd9bac48cbe790e5e0ea38ef776","source_id":"us-ga","stale":false,"prev":"us-ga/o.c.g.a.-31-52-3","next":"us-ga/o.c.g.a.-31-52-5"},"notice":"GroundRules: Original legal text. Not legal advice."}